BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29515772)

  • 1. The c-Raf modulator RRD-251 enhances nuclear c-Raf/GSK-3/VDR axis signaling and augments 1,25-dihydroxyvitamin D3-induced differentiation of HL-60 myeloblastic leukemia cells.
    Supnick HT; Bunaciu RP; Yen A
    Oncotarget; 2018 Feb; 9(11):9808-9824. PubMed ID: 29515772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RRD-251 enhances all-trans retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells.
    Wallace AS; Supnick HT; Bunaciu RP; Yen A
    Oncotarget; 2016 Jul; 7(29):46401-46418. PubMed ID: 27331409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
    Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raf-1 signaling is required for the later stages of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells but is not mediated by the MEK/ERK module.
    Wang X; Studzinski GP
    J Cell Physiol; 2006 Nov; 209(2):253-60. PubMed ID: 16883571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roscovitine enhances all-
    Rashid A; Duan X; Gao F; Yang M; Yen A
    Oncotarget; 2020 Mar; 11(12):1017-1036. PubMed ID: 32256976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased nuclear expression and transactivation of vitamin D receptor by the cardiotonic steroid bufalin in human myeloid leukemia cells.
    Amano Y; Cho Y; Matsunawa M; Komiyama K; Makishima M
    J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):144-51. PubMed ID: 19429444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation.
    Janik S; Nowak U; Łaszkiewicz A; Satyr A; Majkowski M; Marchwicka A; Śnieżewski Ł; Berkowska K; Gabryś M; Cebrat M; Marcinkowska E
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced myelomonocytic differentiation in leukemia cells is accompanied by noncanonical transcription factor expression.
    Jensen HA; Yourish HB; Bunaciu RP; Varner JD; Yen A
    FEBS Open Bio; 2015; 5():789-800. PubMed ID: 26566473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of vitamin D receptor expression by retinoic acid receptor alpha in acute myeloid leukemia cells.
    Marchwicka A; Cebrat M; Łaszkiewicz A; Śnieżewski Ł; Brown G; Marcinkowska E
    J Steroid Biochem Mol Biol; 2016 May; 159():121-30. PubMed ID: 26969398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
    Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
    Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated Differentiation.
    Gupta K; Stefan T; Ignatz-Hoover J; Moreton S; Parizher G; Saunthararajah Y; Wald DN
    Cancer Res; 2016 May; 76(9):2743-53. PubMed ID: 26964622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.
    Garay E; Donnelly R; Wang X; Studzinski GP
    J Cell Physiol; 2007 Dec; 213(3):816-25. PubMed ID: 17520689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells.
    Ibabao CN; Bunaciu RP; Schaefer DM; Yen A
    FEBS Open Bio; 2015; 5():308-18. PubMed ID: 25941627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid causes MEK-dependent RAF phosphorylation through RARalpha plus RXR activation in HL-60 cells.
    Hong HY; Varvayanis S; Yen A
    Differentiation; 2001 Aug; 68(1):55-66. PubMed ID: 11683493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AML-associated translocation products block vitamin D(3)-induced differentiation by sequestering the vitamin D(3) receptor.
    Puccetti E; Obradovic D; Beissert T; Bianchini A; Washburn B; Chiaradonna F; Boehrer S; Hoelzer D; Ottmann OG; Pelicci PG; Nervi C; Ruthardt M
    Cancer Res; 2002 Dec; 62(23):7050-8. PubMed ID: 12460926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway.
    Studzinski GP; Wang X; Ji Y; Wang Q; Zhang Y; Kutner A; Harrison JS
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):47-55. PubMed ID: 16046262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
    Hughes PJ; Brown G
    J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
    Yoon JS; Kim JY; Park HK; Kim ES; Ahn KS; Yoon SS; Cho CG; Kim BK; Lee YY
    Int J Oncol; 2008 Feb; 32(2):387-96. PubMed ID: 18202761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.